Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.22%623.8M | -16.34%380.34M | -11.12%217.54M | 13.61%907.56M | 10.30%665.16M | 20.69%454.63M | 26.21%244.76M | 7.66%798.87M | -0.32%603.04M | -0.99%376.7M |
| Operating revenue | -6.22%623.8M | -16.34%380.34M | -11.12%217.54M | 13.61%907.56M | 10.30%665.16M | 20.69%454.63M | 26.21%244.76M | 7.66%798.87M | -0.32%603.04M | -0.99%376.7M |
| Other operating revenue | ---- | -21.54%1.28M | ---- | 56.08%3.25M | ---- | 63.01%1.64M | ---- | 22.83%2.08M | ---- | 12.05%1M |
| Total operating cost | -2.08%593.07M | -11.77%358.01M | -7.23%200.01M | 13.59%841.54M | 9.24%605.66M | 15.42%405.78M | 19.34%215.6M | 10.39%740.87M | 4.03%554.43M | 5.05%351.57M |
| Operating cost | -2.06%517.96M | -12.65%310.76M | -7.44%176.11M | 12.31%730.7M | 7.86%528.87M | 14.85%355.77M | 19.72%190.26M | 11.99%650.61M | 4.93%490.31M | 6.13%309.76M |
| Operating tax surcharges | 0.26%7.29M | -3.85%4.73M | -15.15%2.55M | 27.12%9.37M | 22.34%7.27M | 22.80%4.92M | 42.31%3.01M | -12.69%7.37M | -2.07%5.95M | 1.38%4.01M |
| Operating expense | 21.53%4.23M | 28.74%2.68M | 23.37%1.3M | 13.31%5.13M | 4.61%3.48M | 0.12%2.08M | -7.10%1.06M | 6.15%4.53M | 10.04%3.33M | 13.76%2.08M |
| Administration expense | 7.45%41.24M | 10.69%27.29M | 10.36%12.96M | 23.15%56.62M | 16.90%38.38M | 11.10%24.65M | 9.39%11.75M | 1.61%45.98M | -0.47%32.83M | -0.85%22.19M |
| Financial expense | -1,535.62%-3.67M | -1,780.71%-4.7M | -1,483.00%-1.83M | 113.03%346.23K | 91.61%-224.17K | 110.75%279.86K | -192.75%-115.39K | -40.46%-2.66M | -28.32%-2.67M | -60.45%-2.6M |
| -Interest expense (Financial expense) | -56.03%876.47K | -57.20%611.32K | -19.37%372.96K | 215.01%2.31M | 407.39%1.99M | 840.77%1.43M | --462.55K | -1.92%732.6K | -1.63%392.89K | 3,494.79%151.82K |
| -Interest Income (Financial expense) | 17.12%-2.25M | 21.67%-1.47M | 27.53%-699.73K | -36.35%-3.37M | -54.79%-2.71M | -74.61%-1.88M | -175.52%-965.49K | -50.01%-2.47M | -31.18%-1.75M | 14.36%-1.08M |
| Research and development | -6.70%26.01M | -4.54%17.25M | -7.61%8.91M | 12.37%39.38M | 12.92%27.88M | 11.99%18.07M | 26.49%9.64M | 2.83%35.05M | -3.80%24.69M | -0.75%16.13M |
| Credit Impairment Loss | -2,469.97%-1.13M | 9,947.48%4.45M | 189.34%1.83M | 54.03%-1.64M | 101.17%47.64K | 101.93%44.32K | 37.61%-2.05M | -207.16%-3.56M | -230.80%-4.07M | -256.70%-2.29M |
| Asset Impairment Loss | -6.20%-165.35K | -125.37%-302.78K | -31.32%517.55K | 102.56%18.53K | -126.03%-155.69K | 68.11%1.19M | -49.50%753.61K | 64.83%-723.96K | 2,026.16%598.06K | 871.54%710.05K |
| Other net revenue | -41.54%7.02M | 5.76%10.78M | 80.27%6.46M | 2.18%14.4M | 17.79%12.01M | 33.17%10.2M | 55.14%3.58M | 7.53%14.1M | 18.81%10.19M | 16.84%7.66M |
| Fair value change income | 5.96%1.04M | -31.67%1.83M | -26.49%1.16M | 8.07%1.7M | 6.64%979.59K | 104.16%2.68M | -36.71%1.57M | 180.64%1.57M | --918.63K | --1.31M |
| Invest income | -41.38%3.57M | -53.14%1.27M | -63.34%239.64K | -23.90%7.28M | -22.42%6.08M | -45.40%2.71M | -39.09%653.6K | 35.84%9.57M | 28.50%7.84M | 59.42%4.96M |
| Asset deal income | ---2.7K | ---2.7K | 10.00%-2.7K | 209.41%29.85K | ---- | --0 | ---3K | -152.00%-27.28K | --52.8K | --65.36K |
| Other revenue | -26.51%3.71M | -1.01%3.54M | 2.21%2.72M | -3.56%7.02M | 4.15%5.05M | 22.99%3.57M | 386.51%2.66M | 73.70%7.27M | 29.76%4.85M | 40.14%2.91M |
| Operating profit | -47.20%37.75M | -43.92%33.11M | -26.73%23.99M | 11.55%80.42M | 21.60%71.5M | 80.11%59.05M | 110.15%32.74M | -14.18%72.09M | -27.07%58.8M | -37.38%32.78M |
| Add:Non operating Income | -83.61%6.9K | -90.52%3.99K | -41.90%3.99K | -89.55%21.05K | -57.53%42.07K | 4,836.03%42.07K | 2,287,926.67%6.86K | 316.01%201.41K | -4.73%99.06K | -97.34%852.33 |
| Less:Non operating expense | 102.89%348.97K | 97.62%271.69K | -27.21%35.27K | -19.26%1.74M | 39.79%172K | 118.28%137.48K | 2.45%48.46K | 506.34%2.15M | -62.80%123.04K | -75.96%62.99K |
| Total profit | -47.59%37.41M | -44.29%32.84M | -26.73%23.96M | 12.20%78.71M | 21.43%71.37M | 80.16%58.95M | 110.52%32.7M | -16.19%70.15M | -26.90%58.78M | -37.23%32.72M |
| Less:Income tax cost | -54.89%2.87M | -49.38%3.13M | -3.32%3.15M | 68.04%8.33M | 8.31%6.35M | 102.80%6.18M | 95.70%3.26M | -27.71%4.95M | -31.86%5.87M | -45.28%3.05M |
| Net profit | -46.87%34.54M | -43.69%29.71M | -29.32%20.81M | 7.96%70.38M | 22.89%65.02M | 77.84%52.77M | 112.30%29.45M | -15.17%65.19M | -26.30%52.91M | -36.26%29.67M |
| Net profit from continuing operation | -46.87%34.54M | -43.69%29.71M | -29.32%20.81M | 7.96%70.38M | 22.89%65.02M | 77.84%52.77M | 112.30%29.45M | -15.17%65.19M | -26.30%52.91M | -36.26%29.67M |
| Net profit of parent company owners | -46.87%34.54M | -43.69%29.71M | -29.32%20.81M | 7.96%70.38M | 22.89%65.02M | 77.84%52.77M | 112.30%29.45M | -15.17%65.19M | -26.30%52.91M | -36.26%29.67M |
| Earning per share | ||||||||||
| Basic earning per share | -47.65%0.3157 | -44.92%0.2715 | -32.14%0.19 | 6.56%0.65 | 21.59%0.6031 | 77.17%0.4929 | 115.38%0.28 | -17.57%0.61 | -28.35%0.496 | -38.91%0.2782 |
| Diluted earning per share | -47.65%0.3157 | -44.92%0.2715 | -32.14%0.19 | 6.56%0.65 | 21.59%0.6031 | 77.17%0.4929 | 115.38%0.28 | -17.57%0.61 | -28.35%0.496 | -38.91%0.2782 |
| Other composite income | ||||||||||
| Total composite income | -46.87%34.54M | -43.69%29.71M | -29.32%20.81M | 7.96%70.38M | 22.89%65.02M | 77.84%52.77M | 112.30%29.45M | -15.17%65.19M | -26.30%52.91M | -36.26%29.67M |
| Total composite income of parent company owners | -46.87%34.54M | -43.69%29.71M | -29.32%20.81M | 7.96%70.38M | 22.89%65.02M | 77.84%52.77M | 112.30%29.45M | -15.17%65.19M | -26.30%52.91M | -36.26%29.67M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.